A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A
lock (
) or https:// means you've safely connected to
the .gov website. Share sensitive information only on official,
secure websites.
NIH has no active Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) Notices of Funding Opportunity (NOFOs); therefore, there is no April 5, 2026 receipt date (see NOT-OD-26-006). Any future NOFOs will be forecasted at Grants.gov prior to opening for applications.
Learn if your company is eligible for NIH SBIR or STTR funding, how to apply, and what to expect during each step of the application process. Multiple registrations are required to prepare your application and apply for funding.
The NIH is actively turning discovery into health by helping small businesses develop innovative technologies that improve health and save lives. See how.
Inomagen Therapeutics is a private, preclinical-stage biotechnology company developing a non-viral gene therapy that targets the underlying mechanisms of Atrial Fibrillation. To achieve safe and effective gene delivery, the company is developing a novel, patented transcatheter gene delivery system.